Cue’s COVID-19 test is being used throughout the U.S. in clinical and point-of-care settings, such as community health clinics, doctor’s offices, nursing homes, correctional facilities, and schools, as well as in homes and other nonclinical settings. Since June 2020, Cue has been helping to meet the COVID-19 testing needs of rural communities, tribal nations, world class organizations, and federal agencies such as the U.S. Department of Defense and the U.S. Department of Health and Human Services.

Cue’s COVID-19 molecular test was authorized for professional use in June 2020 and for consumer use without a prescription in March 2021.